ALPHA TRIBE

Suven Life Sciences LimitedUpdates, 08-07-2026: General Updates

08-07-2026 | 04:51 pm

Suven Life Sciences allotted 1.86 Cr shares via warrant conversion, raising ₹248.84 Cr, significantly boosting its paid-up capital. The company is also incorporating a Singapore subsidiary for biopharmaceutical clinical development, involving an investment of up to $100M.

No comments yet. Be the first to comment!

All announcements from Suven Life Sciences Limited